22,500 Shares in Monte Rosa Therapeutics, Inc. $GLUE Acquired by Bailard Inc.
Bailard Inc. bought a new position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange...